Gene Biotherapeutics, Inc. Current Assets
Gene Biotherapeutics, Inc. had Current Assets of $410.64 thousand as of 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2022-04-14
- 2020-12-31: Assets, Current $410.64K.
- 2020-09-30: Assets, Current $800.75K.
- 2020-06-30: Assets, Current $1.33M.
- 2020-03-31: Assets, Current $114.91K.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2020-12-31 | $410.64K 10-K/A · filed 2022-04-14 | |
| 2020-09-30 | $800.75K 10-Q · filed 2021-10-27 | |
| 2020-06-30 | $1.33M 10-Q · filed 2021-09-17 | |
| 2020-03-31 | $114.91K 10-Q · filed 2021-09-03 | |
| 2019-12-31 | $32.80K 10-K/A · filed 2022-04-14 | |
| 2019-09-30 | $54.02K 10-K · filed 2021-04-23 | |
| 2019-06-30 | $12.86K 10-K · filed 2021-04-23 | |
| 2019-03-31 | $18.07K 10-K · filed 2021-04-23 | |
| 2018-12-31 | $101.08K 10-K · filed 2021-04-23 | |
| 2018-09-30 | $199.72K 10-K · filed 2021-04-23 | |
| 2018-06-30 | $48.35K 10-K · filed 2021-04-23 | |
| 2018-03-31 | $12.71K 10-K · filed 2021-04-23 | |
| 2017-12-31 | $73.99K 10-K · filed 2021-04-23 | |
| 2017-09-30 | $18.66K 10-K · filed 2021-04-23 | |
| 2017-06-30 | $52.69K 10-K · filed 2021-04-23 | |
| 2017-03-31 | $215.57K 10-K · filed 2021-04-23 | |
| 2016-12-31 | $940.82K 10-K · filed 2017-07-28 | |
| 2016-09-30 | $1.79M 10-Q · filed 2017-03-21 | |
| 2016-06-30 | $12.85K 10-Q · filed 2017-03-06 | |
| 2016-03-31 | $128.51K 10-Q · filed 2017-03-01 | |
| 2015-12-31 | $30.78K 10-K · filed 2017-07-28 | |
| 2015-09-30 | $38.05K 10-Q · filed 2016-10-27 | |
| 2015-06-30 | $148.86K 10-Q · filed 2016-08-29 | |
| 2015-03-31 | $227.15K 10-Q · filed 2015-06-18 | |
| 2014-12-31 | $419.69K 10-K · filed 2016-12-29 | |
| 2014-09-30 | $453.36K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $1.18M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $737.19K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $491.52K 10-K · filed 2015-05-22 | |
| 2013-09-30 | $1.85M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $2.14M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $2.03M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $4.29M 10-K · filed 2014-04-15 | |
| 2012-09-30 | $5.99M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $7.29M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $9.77M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $5.37M 10-K · filed 2013-04-05 | |
| 2011-09-30 | $2.60M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $4.55M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $7.91M 10-K · filed 2012-03-30 | $8.00M 10-Q · filed 2011-08-15 |